{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:13:34Z","timestamp":1789236814283,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04109-1","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:01:52Z","timestamp":1727420512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Therapeutic inertia and contributing factors among ambulatory patients with hypertension"],"prefix":"10.1186","volume":"24","author":[{"given":"Yirga Legesse","family":"Niriayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Girmay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigusse","family":"Tesfay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidu","family":"Gidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Weldegebreal","family":"Asgedom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"6","key":"4109_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and ControlClinical Perspective: a systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134(6):441\u201350.","journal-title":"Circulation"},{"issue":"4","key":"4109_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4109_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5334\/aogh.2591","volume":"86","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Chen J, Xiao C, Chen W. A Global View on Prevalence of Hypertension and Human develop Index. Ann Glob Health. 2020;86(1):67.","journal-title":"Ann Glob Health"},{"issue":"6","key":"4109_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/HJH.0000000000002021","volume":"37","author":"BM Egan","year":"2019","unstructured":"Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019;37(6):1148\u201353.","journal-title":"J Hypertens"},{"issue":"2","key":"4109_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and systolic blood pressure of at least 110 to 115\u00a0mm hg, 1990\u20132015. JAMA. 2017;317(2):165\u201382.","journal-title":"JAMA"},{"issue":"10","key":"4109_CR6","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1016\/S2214-109X(19)30370-5","volume":"7","author":"JJ Bigna","year":"2019","unstructured":"Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-saharan Africa. Lancet Global Health. 2019;7(10):e1295\u20136.","journal-title":"Lancet Global Health"},{"issue":"4","key":"4109_CR7","first-page":"152","volume":"26","author":"NRC Campbell","year":"2015","unstructured":"Campbell NRC, Lemogoum D. Hypertension in sub-saharan Africa: a massive and increasing health disaster awaiting solution. Cardiovasc J Afr. 2015;26(4):152\u20134.","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"4109_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12872-020-01414-3","volume":"20","author":"F Amare","year":"2020","unstructured":"Amare F, Hagos B, Sisay M, Molla B. Uncontrolled hypertension in Ethiopia: a systematic review and meta-analysis of institution-based observational studies. BMC Cardiovasc Disord. 2020;20(1):129.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"4109_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.11648\/j.sjph.20150304.19","volume":"3","author":"M Molla","year":"2015","unstructured":"Molla M. Systematic reviews of prevalence and associated factors of hypertension in Ethiopia: finding the evidence. Sci J Public Health. 2015;3(4):514\u20139.","journal-title":"Sci J Public Health"},{"issue":"1","key":"4109_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40985-015-0014-z","volume":"36","author":"KT Kibret","year":"2015","unstructured":"Kibret KT, Mesfin YM. Prevalence of hypertension in Ethiopia: a systematic meta-analysis. Public Health Rev. 2015;36(1):1\u201312.","journal-title":"Public Health Rev"},{"key":"4109_CR11","unstructured":"World Health Organization. Noncommunicable diseases country profiles 2018. 2018."},{"issue":"5","key":"4109_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320. Epub 2013\/12\/20.","journal-title":"JAMA"},{"key":"4109_CR13","unstructured":"Danaei G, Lu Y, Singh GM, Carnahan E, Stevens GA, Cowan MJ, et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes & Endocrinology; 2014."},{"issue":"19","key":"4109_CR14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201371.","journal-title":"JAMA"},{"key":"4109_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.HYP.0000142248.54761.56","volume":"44","author":"LEBV Fields","year":"2004","unstructured":"Fields LEBV, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398\u2013404.","journal-title":"Hypertension"},{"issue":"2","key":"4109_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/oxfordjournals.bmb.a072892","volume":"50","author":"R Collins","year":"1994","unstructured":"Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50(2):272\u201398.","journal-title":"Br Med Bull"},{"issue":"9246","key":"4109_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","volume":"356","author":"B Neal","year":"2000","unstructured":"Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists\u2019 collaboration. Lancet (London England). 2000;356(9246):1955\u201364.","journal-title":"Lancet (London England)"},{"issue":"5","key":"4109_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, Ortiz E. Evidence-based guideline for the management of 18 high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014;311(5):507\u201320. https:\/\/doi.org\/10.1001\/jama.2013.284427.","journal-title":"JAMA"},{"key":"4109_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2261-13-54","volume":"13","author":"J Kayima","year":"2013","unstructured":"Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013;13:54. https:\/\/doi.org\/10.1186\/1471-2261-13-54.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"4109_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jch.12237","volume":"16","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;16(1):14\u201326.","journal-title":"J Clin Hypertens"},{"issue":"3","key":"4109_CR21","first-page":"94","volume":"8","author":"MAB Beigi","year":"2014","unstructured":"Beigi MAB, Zibaeenezhad MJ, Aghasadeghi K, Jokar A, Shekarforoush S, Khazraei H. The effect of educational programs on hypertension management. Int Cardiovasc Res J. 2014;8(3):94.","journal-title":"Int Cardiovasc Res J"},{"issue":"6","key":"4109_CR22","doi-asserted-by":"publisher","first-page":"e0218947","DOI":"10.1371\/journal.pone.0218947","volume":"14","author":"YL Niriayo","year":"2019","unstructured":"Niriayo YL, Ibrahim S, Kassa TD, Asgedom SW, Atey TM, Gidey K, et al. Practice and predictors of self-care behaviors among ambulatory patients with hypertension in Ethiopia. PLoS ONE. 2019;14(6):e0218947. https:\/\/doi.org\/10.1371\/journal.pone.0218947. Epub 2019\/06\/27.","journal-title":"PLoS ONE"},{"key":"4109_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","volume":"22","author":"PMWM Kearney","year":"2004","unstructured":"Kearney PMWM, Reynolds K, et al. ;. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11\u20139.","journal-title":"J Hypertens"},{"issue":"9","key":"4109_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368.","journal-title":"JAMA"},{"issue":"4","key":"4109_CR25","doi-asserted-by":"publisher","first-page":"e001217","DOI":"10.1136\/bmjopen-2012-001217","volume":"2","author":"A Dzudie","year":"2012","unstructured":"Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam CK, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-saharan African urban population: a cross-sectional study. BMJ open. 2012;2(4):e001217.","journal-title":"BMJ open"},{"issue":"3","key":"4109_CR26","first-page":"1086","volume":"4","author":"HA Hareri","year":"2013","unstructured":"Hareri HA, Abebe M, Asefaw T. Assessments of adherence to hypertension managements and its influencing factors among hypertensive patients attending black lion hospital chronic follow up unit, Addis Ababa, Ethiopia-a cross-sectional study. Int J Pharm Sci Res. 2013;4(3):1086.","journal-title":"Int J Pharm Sci Res"},{"issue":"5","key":"4109_CR27","doi-asserted-by":"publisher","first-page":"e0196535","DOI":"10.1371\/journal.pone.0196535","volume":"13","author":"DF Teshome","year":"2018","unstructured":"Teshome DF, Demssie AF, Zeleke BM. Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia. PLoS ONE. 2018;13(5):e0196535.","journal-title":"PLoS ONE"},{"issue":"1","key":"4109_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s13104-019-4630-4","volume":"12","author":"AY Aschalew","year":"2019","unstructured":"Aschalew AY, Yitayal M, Minyihun A, Bisetegn TA. Self-care practice and associated factors among patients with diabetes mellitus on follow up at University of Gondar Referral Hospital, Gondar, Northwest Ethiopia. BMC Res Notes. 2019;12(1):591.","journal-title":"BMC Res Notes"},{"issue":"5","key":"4109_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10865-008-9165-4","volume":"31","author":"EB Hekler","year":"2008","unstructured":"Hekler EB, Lambert J, Leventhal E, Leventhal H, Jahn E, Contrada RJ. Commonsense illness beliefs, adherence behaviors, and hypertension control among African americans. J Behav Med. 2008;31(5):391\u2013400.","journal-title":"J Behav Med"},{"issue":"3","key":"4109_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/1115-2613.278785","volume":"27","author":"K Douglas","year":"2018","unstructured":"Douglas K, Alabere I. Blood pressure control and associated factors among hypertensive patients in University of Port Harcourt teaching hospital in South-South Nigeria. Niger J Med. 2018;27(3):234\u201344.","journal-title":"Niger J Med"},{"issue":"25","key":"4109_CR31","doi-asserted-by":"publisher","first-page":"e11121","DOI":"10.1097\/MD.0000000000011121","volume":"97","author":"T Milman","year":"2018","unstructured":"Milman T, Joundi RA, Alotaibi NM, Saposnik G. Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis. Medicine. 2018;97(25):e11121\u2013e.","journal-title":"Medicine"},{"issue":"5","key":"4109_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1751-7176.2012.00607.x","volume":"14","author":"AG Huebschmann","year":"2012","unstructured":"Huebschmann AG, Mizrahi T, Soenksen A, Beaty BL, Denberg TD. Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial. J Clin Hypertens (Greenwich Conn). 2012;14(5):322\u20139.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"issue":"9","key":"4109_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","volume":"135","author":"LS Phillips","year":"2001","unstructured":"Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825\u201334.","journal-title":"Ann Intern Med"},{"key":"4109_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2296-15-130","volume":"15","author":"J-P Lebeau","year":"2014","unstructured":"Lebeau J-P, Cadwallader J-S, Aubin-Auger I, Mercier A, Pasquet T, Rusch E, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15:130.","journal-title":"BMC Fam Pract"},{"key":"4109_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/AMEP.S59022","volume":"5","author":"I Aujoulat","year":"2014","unstructured":"Aujoulat I, Jacquemin P, Rietzschel E, Scheen A, Tr\u00e9fois P, Wens J, et al. Factors associated with clinical inertia: an integrative review. Adv Med Educ Pract. 2014;5:141\u20137.","journal-title":"Adv Med Educ Pract"},{"issue":"1\u20132","key":"4109_CR36","first-page":"24","volume":"40","author":"PD Byrnes","year":"2011","unstructured":"Byrnes PD. Why haven\u2019t I changed that? Therapeutic inertia in general practice. Aus Fam Physician. 2011;40(1\u20132):24\u20138. Epub 2011\/02\/09. PubMed PMID: 21301689.","journal-title":"Aus Fam Physician"},{"issue":"5\u20136","key":"4109_CR37","first-page":"232","volume":"65","author":"AJ Scheen","year":"2010","unstructured":"Scheen AJ. [Inertia in clinical practice: causes, consequences, solutions]. Rev Med Liege. 2010;65(5\u20136):232\u20138.","journal-title":"Rev Med Liege"},{"issue":"6","key":"4109_CR38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"4","key":"4109_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/MLR.0b013e31818d775c","volume":"47","author":"JV Selby","year":"2009","unstructured":"Selby JV, Uratsu CS, Fireman B, Schmittdiel JA, Peng T, Rodondi N, et al. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009;47(4):395\u2013402.","journal-title":"Med Care"},{"issue":"7","key":"4109_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7326\/0003-4819-144-7-200604040-00006","volume":"144","author":"N Rodondi","year":"2006","unstructured":"Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144(7):475\u201384.","journal-title":"Ann Intern Med"},{"issue":"3","key":"4109_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","volume":"47","author":"EC Okonofua","year":"2006","unstructured":"Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47(3):345\u201351.","journal-title":"Hypertension"},{"issue":"22","key":"4109_CR42","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1161\/CIRCULATIONAHA.107.724104","volume":"117","author":"M Heisler","year":"2008","unstructured":"Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008;117(22):2884\u201392.","journal-title":"Circulation"},{"issue":"5","key":"4109_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s11606-008-0554-8","volume":"23","author":"JA Schmittdiel","year":"2008","unstructured":"Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don\u2019t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588\u201394.","journal-title":"J Gen Intern Med"},{"key":"4109_CR44","unstructured":"Henriksen K. Advances in patient safety: from research to implementation. Agency for Healthcare Research and Quality; 2005."},{"issue":"12","key":"4109_CR45","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2165\/11596640-000000000-00000","volume":"28","author":"V Gil-Guill\u00e9n","year":"2011","unstructured":"Gil-Guill\u00e9n V, Orozco-Beltr\u00e1n D, M\u00e1rquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fern\u00e1ndez S, et al. Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging. 2011;28(12):981\u201392.","journal-title":"Drugs Aging"},{"issue":"3","key":"4109_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/jhh.2008.117","volume":"23","author":"P Ferrari","year":"2009","unstructured":"Ferrari P. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-western countries. J Hum Hypertens. 2009;23(3):151\u20139.","journal-title":"J Hum Hypertens"},{"key":"4109_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jash.2009.03.001","volume":"3","author":"CWM Faria","year":"2009","unstructured":"Faria CWM, Lee KW, Coderre K, Nichols J, Belletti. DA:. A narrative review of clinical inertia: focus on hypertension. J Am Soc Hypertens. 2009;3:267\u201376.","journal-title":"J Am Soc Hypertens"},{"key":"4109_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1524-6175.2007.06112.x","volume":"9","author":"GCB Ardery","year":"2007","unstructured":"Ardery GCB, Milchak JL, Bergus GR, Dawson JD, James PA, Franciscus C, Kim Y. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens. 2007;9:113\u20139.","journal-title":"J Clin Hypertens"},{"issue":"1","key":"4109_CR49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12913-017-2305-1","volume":"17","author":"AI Bilal","year":"2017","unstructured":"Bilal AI, Tilahun Z, Gebretekle GB, Ayalneh B, Hailemeskel B, Engidawork E. Current status, challenges and the way forward for clinical pharmacy service in Ethiopian public hospitals. BMC Health Serv Res. 2017;17(1):359.","journal-title":"BMC Health Serv Res"},{"key":"4109_CR50","doi-asserted-by":"crossref","unstructured":"Goverwa TPMN, Tshimanga M, Gombe NT, Takundwa L, Bangure D et al. Uncontrolled hypertension among hypertensive patients on treatment in Lupane District,Zimbabwe. BioMed Central Research Notes. 2014; 7(703) 2012.","DOI":"10.1186\/1756-0500-7-703"},{"key":"4109_CR51","doi-asserted-by":"crossref","unstructured":"Mutua EM GM Mbuthiab, Muiruri N, Cheptum JJ, Maingi T. Level of blood pressure control among hypertensive patients on follow-up in a Regional Referral Hospital in Central Kenya. PanAfrican Medical Journal. 2014: 18(278).","DOI":"10.11604\/pamj.2014.18.278.4308"},{"issue":"1","key":"4109_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4102\/phcfm.v5i1.446","volume":"5","author":"GUP Iloh","year":"2013","unstructured":"Iloh GUP, Ofoedu JN, Njoku PU, Amadi AN, Godswill-Uko EU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr J Prim Health Care Fam Med. 2013;5(1):446.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"4109_CR53","doi-asserted-by":"publisher","first-page":"405892","DOI":"10.1155\/2012\/405892","volume":"2012","author":"D Sandoval","year":"2012","unstructured":"Sandoval D, Bravo M, Koch E, Gatica S, Ahlers I, Henr\u00edquez O, et al. Overcoming barriers in the management of hypertension: the experience of the cardiovascular health program in Chilean primary health care centers. Int J Hypertens. 2012;2012:405892.","journal-title":"Int J Hypertens"},{"issue":"2","key":"4109_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/20786204.2012.10874196","volume":"54","author":"SC Onwukwe","year":"2012","unstructured":"Onwukwe SC, Omole OB. Drug therapy, lifestyle modification and blood pressure control in a primary care facility, south of Johannesburg, South Africa: an audit of hypertension management. South Afr Family Pract. 2012;54(2):156\u201361.","journal-title":"South Afr Family Pract"},{"issue":"8","key":"4109_CR55","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1097\/HJH.0b013e32833b4953","volume":"28","author":"J Red\u00f3n","year":"2010","unstructured":"Red\u00f3n J, Coca A, L\u00e1zaro P, Aguilar MD, Caba\u00f1as M, Gil N, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens. 2010;28(8):1770\u20137.","journal-title":"J Hypertens"},{"issue":"5","key":"4109_CR56","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.clinthera.2012.04.003","volume":"34","author":"F Zeng","year":"2012","unstructured":"Zeng F, Plauschinat PJ, Patel CA. Failure to intensify hypertension therapy after rejected aliskiren claims. Clin Ther. 2012;34(5):1122\u201331.","journal-title":"Clin Ther"},{"issue":"1","key":"4109_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11906-018-0802-1","volume":"20","author":"R Josiah Willock","year":"2018","unstructured":"Josiah Willock R, Miller JB, Mohyi M, Abuzaanona A, Muminovic M, Levy PD. Therapeutic inertia and treatment intensification. Curr Hypertens Rep. 2018;20(1):4.","journal-title":"Curr Hypertens Rep"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04109-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:02:36Z","timestamp":1727424156000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04109-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4109"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04109-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics review committee of the School of Pharmacy, College of Health Sciences, Mekelle University, for this study. The purpose and protocol of the study were thoroughly explained to all participants included in the study. Each patient provided written informed consent, ensuring their participation was voluntary. Strict confidentiality measures were in place to protect personal information. All methods employed in this study were conducted in compliance with approved institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"523"}}